RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
Opaganib completely inhibited SARS-CoV-2 viral replication as measured after three days incubation in an in vitro model of human bronchial […]
AquaBounty Technologies to Present at Upcoming Investor Conferences in September
MAYNARD, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture […]
Micron Launches Limited Edition Crucial® Ballistix® MAX 5100 Gaming DRAM, Offering the Fastest Speed Available on the Market
Key Highlights:Crucial® Ballistix® MAX 5100 memory is the fastest available on the market1New offering expands the award-winning Crucial Ballistix gaming […]
PMV Pharma Appoints Laurie Stelzer to the Board of Directors and Robert Ticktin as General Counsel
CRANBURY, N. J., Sept. 08, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and […]
STRATA Skin Sciences to Present at Two Upcoming Investor Conferences
HORSHAM, Penn., Sept. 08, 2020 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in […]
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Pivotal Phase 3 clinical trial of oral tebipenem HBr met primary endpoint, demonstrating statistical non-inferiority versus intravenous ertapenem in patients […]
